Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 109-120

  McMahon, Lance R ^a   France, Charles P ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXY 5BETA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; ABECARNIL; ANDROSTANEDIOL; ANDROSTERONE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; DIAZEPAM; DIPHENHYDRAMINE; FLUMAZENIL; FLUNITRAZEPAM; KETAMINE; MIDAZOLAM; SEDATIVE AGENT; STEROID; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG BINDING SITE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DIAZEPAM; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUMAZENIL; GABA MODULATORS; HYPNOTICS AND SEDATIVES; MACACA MULATTA; MALE; MIDAZOLAM; RECEPTORS, GABA-A; STEROIDS;

EID: 0037215531     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.040931     Document Type: Article

References (31)

1. Bruni J and Wilder BJ (1979) Valproic acid. Review of a new antiepileptic drug. Arch Neurol 36:393-398.
2. Davis LL, Ryan W, Adinoff B, and Petty F (2000) Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol 20:1S-17S.
3. Evans SM and Johanson CE (1989) Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J Pharmacol Exp Ther 250:779-787.
4. File SE and Andrews N (1991) Low but not high doses of buspirone reduce the anxiogenic effects ofdiazepam withdrawal. Psychopharmacology 105:578-582.
5. Gee KW, Bolger MB, Brinton RE, Coirini H, and McEwen BS (1988) Steroid modulation of the chloride ionophore in rat brain: Structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246:803-812.
6. Gerak LR and France CP (1999) Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys. Psychopharmacology 146: 252-261.
7. Goldberg HL (1984) Buspirone hydrochloride: A unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy. Pharmacotherapy 4:315-324.
8. Harris JT, Roache JD, and Thornton JE (2000) A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention. Alcohol 35: 319-323.
9. Hoffman A and Habib G (1994) Valproic acid intensifies the depressant action of phenobarbital and ethanol by a pharmacodynamic mechanism. J Pharm Sci 83: 733-735.
10. Kubo N, Shirakawa O, Kuno T, and Tanaka C (1987) Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor-binding assay. Jpn J Pharmacol 43:277-282.
11. Lader M and Olajide D (1987) A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms. J Clin Psychopharmacol 7:11-15.
12. Lelas S, Gerak LR, and France CP (1999) Discriminative stimulus effects of triazolam and midazolam in rhesus monkeys. Behav Pharmacol 10:39-50.
13. A modulators in rhesus monkeys discriminating midazolam. J Pharmacol Exp Ther 294:902-908.
14. Lukas SE and Griffiths RR (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science (Wash DC) 217:1161-1163.
15. Mamelak M, Escriu JM, and Stokan O (1977) The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry 12:273-288.
16. A modulators triazolam and pregnanolone in rhesus monkeys. Psychopharmacology 158:289-296.
17. 1 receptor-selective ligands in rhesus monkeys. J Pharmacol Exp Ther 300:505-512.
18. A modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam treated monkeys. J Pharmacol Exp Ther 298:1227-1235.
19. 3H]flunitrazepam binding in vivo. Eur J Pharmacol 87:499-500.
20. A receptor function through distinct sites. Brain Res 830:72-87.
21. A receptor complex in avian CNS. Neurochem Res 22:221-225.
22. Rickels K, Schweizer E, Garcia Espana F, Case G, DeMartinis N, and Greenblatt D (1999) Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal symptoms and taper outcome. Psychopharmacology 141:1-5.
23. Sadove MS, Shulman M, Hatano S, and Fevold N (1971) Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg 50:452-457.
24. Schweizer E and Rickels K (1986) Failure of buspirone to manage benzodiazepine withdrawal. Am J Psychiatry 143:1590-1592.
25. 36Cl ion flux. Mol Pharmacol 59:1108-1118.
26. Spealman RD (1985) Discriminative-stimulus effects of midazolam in squirrel monkeys: Comparison with other drugs and antagonism by Ro 15-1788. J Pharmacol Exp Ther 235:456-462.
27. Sunshine A, Zighelboim I, and Laska E (1978) Hypnotic activity of diphenhydramine, methapyrilene and placebo. J Clin Pharmacol 18:425-431.
28. Turner DM, Ransom RW, Yang JS, and Olsen RW (1989) Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther 248:960-966.
29. Uhlenhuth EH (1982) Buspirone: A clinical review of a new, non-benzodiazepine anxiolytic. J Clin Psychiatry 43:109-116.
30. Woods JH, Katz JL, and Winger G (1992) Benzodiazepines: Use, abuse and consequences. Pharmacol Rev 44:151-347.
31. Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, and France CP (1999) Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug Alcohol Depend 54:137-143.